| [1] |
MA Yan, TIAN Gaopeng, SHI Xingwen, SUN Ting, XIE Jingjing, ZHEN Donghu.
Correlation between 25(OH)D and metabolically related fatty liver in T2DM population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1018-1026.
|
| [2] |
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, GCP Center Phase I Clinical Trial Ward, Shenyang , Liaonning, China.
Bioequivalence of rosuvastatin calcium tablets in Chinese healthy subjects
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(12): 1369-1375.
|
| [3] |
LI Jiadan，LU Chen.
Synergistic effects of Cortex Mori alkaloids combined with Simvastatin in rats with hyperlipidaemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(3): 278-284.
|
| [4] |
LIU Xiaohong, LI Ling, QI Zhenhua, CHEN Binyao, ZHAO Huijia, HAO Zhuowen, YUE Jiang, YE Qifa，WU Jianguo.
Farnesoid X receptor is an important target in lipid metabolism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(8): 955-960.
|
| [5] |
JIANG Hai, JIANG Guozhi, CHEN Zhong, LI Zhenjiang.
Lipid-lowering effects of combined use of curcuma longa L.extracts and atorvastatin calcium in hyperlipidemia mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 48-51.
|
| [6] |
FAN Lei, SONG Hong-tao, XU Rong-qing, XU Zheng-wei.
Correlation between Apolipoprotein CⅠ gene polymorphisms and lipid-lowering efficacy of atorvastatin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(10): 1161-1165.
|
| [7] |
DENG Zu-yue, KANG Hua, XIN Yan-fei, KUANG Rong.
Effects of tea polyphenols on the serum lipid and inflammation factor in experimental atherosclerosis rabbits
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(3): 279-282.
|
